← Back to guidelines
Hematology12 papers

Tuberculous peritonitis

Last edited: 4/15/2026

Overview

Tuberculous peritonitis is an extrapulmonary manifestation of tuberculosis characterized by inflammation of the peritoneum, often leading to ascites and peritoneal adhesions 13.

Diagnosis

  • Clinical Presentation: May present with ascites, abdominal pain, and nonspecific symptoms 1.
  • Laboratory Findings: Unusual laboratory results can delay diagnosis; thrombocytosis (elevated platelet count) is a rare but noted association 21.
  • Imaging: Not specifically detailed in abstracts but often includes abdominal imaging to assess ascites and peritoneal thickening.
  • Peritoneoscopy: Characteristic findings include miliary tubercles on visceral and parietal peritoneum with adhesions; guided biopsy crucial for definitive diagnosis 3.
  • Biopsy: Essential for confirming diagnosis via histopathological examination and culture 3.
  • Precautions: Special care advised to minimize complications during peritoneoscopy and biopsy procedures 3.
  • Management

  • First-Line Treatment: Standard antitubercular therapy (e.g., isoniazid, rifampin, ethambutol, pyrazinamide) tailored based on sensitivity testing 1.
  • Duration: Typically prolonged therapy lasting 6-9 months, adjusted based on clinical response and drug resistance patterns 1.
  • Adjunctive Measures: Management of ascites and complications like thrombocytosis may require additional supportive care 2.
  • Monitoring: Regular monitoring of liver function, hematological parameters, and clinical response is essential 12.
  • Special Populations

  • Comorbidities: CAPD patients may present with atypical findings, necessitating heightened clinical suspicion 1.
  • Thrombocytosis: Particularly noted in young females, requiring careful monitoring of coagulation status 2.
  • Key Recommendations

  • Perform peritoneoscopy with guided biopsy for definitive diagnosis of tuberculous peritonitis to avoid diagnostic delays (Evidence: Moderate) 3.
  • Initiate standard antitubercular therapy tailored to drug sensitivity, with prolonged duration (6-9 months), for effective management (Evidence: Expert opinion) 1.
  • Exercise caution during peritoneoscopy to minimize complications, especially in patients with suspected tuberculous peritonitis (Evidence: Expert opinion) 3.
  • References

    1 Ludlam H, Jayne D, Phillips I. Mycobacterium tuberculosis as a cause of peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. The Journal of infection 1986. link95007-3) 2 Omar MA, Jogessar VB, Kamdar MC. Thrombocytosis associated with tuberculous peritonitis. Tubercle 1983. link90027-2) 3 Geake TM, Spitaels JM, Moshal MG, Simjee AE. Peritoneoscopy in the diagnosis of tuberculous peritonitis. Gastrointestinal endoscopy 1981. link73152-3)

    Original source

    1. [1]
    2. [2]
      Thrombocytosis associated with tuberculous peritonitis.Omar MA, Jogessar VB, Kamdar MC Tubercle (1983)
    3. [3]
      Peritoneoscopy in the diagnosis of tuberculous peritonitis.Geake TM, Spitaels JM, Moshal MG, Simjee AE Gastrointestinal endoscopy (1981)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG